COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder.
作者信息
Tamburin Stefano, Mantovani Elisa, De Bernardis Ernesto, Zipeto Donato, Lugoboni Fabio
机构信息
Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Piazzale Scuro 10, 37134, Verona, Italy.
Addiction Medicine Unit, Siracusa Province Health Agency, Lentini, Italy.
出版信息
Intern Emerg Med. 2021 Sep;16(6):1729-1731. doi: 10.1007/s11739-021-02633-y. Epub 2021 Jan 19.
Abstract
摘要
相似文献
1
COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder.正在接受双硫仑治疗酒精使用障碍的患者中的新冠病毒疾病及相关症状
Intern Emerg Med. 2021 Sep;16(6):1729-1731. doi: 10.1007/s11739-021-02633-y. Epub 2021 Jan 19.
2
Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.双硫仑的使用与降低 COVID-19 风险相关：一项回顾性队列研究。
PLoS One. 2021 Oct 28;16(10):e0259061. doi: 10.1371/journal.pone.0259061. eCollection 2021.
3
Is Alcohol in Hand Sanitizers Absorbed Through the Skin or Lungs? Implications for Disulfiram Treatment.酒精洗手液中的酒精是否会被皮肤或肺部吸收？对双硫仑治疗的影响。
Alcohol Alcohol. 2020 Jun 25;55(4):354-356. doi: 10.1093/alcalc/agaa045.
4
Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study.双硫仑与劳拉西泮联合治疗酒精依赖及共病焦虑障碍：一项开放标签的试点研究。
Am J Drug Alcohol Abuse. 2016 Sep;42(5):490-499. doi: 10.3109/00952990.2016.1168430. Epub 2016 May 16.
5
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.纳曲酮和双硫仑用于酒精依赖合并精神障碍患者的研究
Biol Psychiatry. 2005 May 15;57(10):1128-37. doi: 10.1016/j.biopsych.2005.02.016.
6
Efficacy of disulfiram for the treatment of alcohol dependence assessed with a multicenter randomized controlled trial.通过多中心随机对照试验评估双硫仑治疗酒精依赖的疗效。
Alcohol Clin Exp Res. 2014 Feb;38(2):572-8. doi: 10.1111/acer.12278. Epub 2013 Oct 11.
7
Naltrexone and disulfiram in patients with alcohol dependence and current depression.纳曲酮和双硫仑用于酒精依赖且目前患有抑郁症的患者。
J Clin Psychopharmacol. 2007 Apr;27(2):160-5. doi: 10.1097/jcp.0b13e3180337fcb.
8
Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety.双硫仑治疗患者的尿乙基葡萄糖醛酸苷评估：一种改善戒酒验证和安全性的工具。
Clin Neuropharmacol. 2010 Nov-Dec;33(6):285-7. doi: 10.1097/WNF.0b013e3181fc9362.
9
Supervised disulfiram in the treatment of alcohol use disorder: a commentary.监督使用双硫仑治疗酒精使用障碍：评论。
Alcohol Clin Exp Res. 2011 Oct;35(10):1732-6. doi: 10.1111/j.1530-0277.2011.01519.x. Epub 2011 May 13.
10
Disulfiram-ethanol induced delirium.双硫仑-乙醇所致谵妄
Ann Pharmacother. 2001 Jan;35(1):32-5. doi: 10.1345/aph.10038.
引用本文的文献
1
The Effect of Disulfiram and N-Acetylcysteine, Potential Compensators for Sulfur Disorders, on Lipopolysaccharide-Induced Neuroinflammation Leading to Memory Impairment and the Metabolism of L-Cysteine Disturbance.双硫仑和N-乙酰半胱氨酸（硫紊乱的潜在补偿剂）对脂多糖诱导的导致记忆障碍的神经炎症及L-半胱氨酸代谢紊乱的影响。
Molecules. 2025 Jan 27;30(3):578. doi: 10.3390/molecules30030578.
2
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.COVID-19治疗潜在药物和疫苗的临床前与临床研究：近期更新的综合综述
Clin Pathol. 2024 Jul 26;17:2632010X241263054. doi: 10.1177/2632010X241263054. eCollection 2024 Jan-Dec.
3
3-chymotrypsin-like protease in SARS-CoV-2.SARS-CoV-2 中的 3-糜蛋白酶样蛋白酶。
Biosci Rep. 2024 Aug 28;44(8). doi: 10.1042/BSR20231395.
4
An Update on SARS-CoV-2 Clinical Trial Results-What We Can Learn for the Next Pandemic.关于 SARS-CoV-2 临床试验结果的最新信息——我们可以从中学到什么以应对下一次大流行。
Int J Mol Sci. 2023 Dec 26;25(1):354. doi: 10.3390/ijms25010354.
5
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism.双硫仑通过调节肠道微生物群和胆汁酸代谢改善非酒精性脂肪性肝炎。
Nat Commun. 2022 Nov 11;13(1):6862. doi: 10.1038/s41467-022-34671-1.
6
Reactivity and binding mode of disulfiram, its metabolites, and derivatives in SARS-CoV-2 PL: insights from computational chemistry studies.抗疟药双硫仑、其代谢物及衍生物在 SARS-CoV-2 主蛋白酶上的反应性和结合模式：计算化学研究的启示。
J Mol Model. 2022 Oct 12;28(11):354. doi: 10.1007/s00894-022-05341-2.
7
Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2.双硫仑通过抑制刺突蛋白与血管紧张素转换酶2的相互作用来阻断严重急性呼吸综合征冠状病毒2的细胞进入。
Am J Cancer Res. 2022 Jul 15;12(7):3333-3346. eCollection 2022.
8
Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases.用于确定新型冠状病毒感染对人类自身免疫性疾病进展影响的系统生物学模型。
Inform Med Unlocked. 2022;32:101003. doi: 10.1016/j.imu.2022.101003. Epub 2022 Jul 6.
9
Reactive Sulfur Compounds in the Fight against COVID-19.对抗新冠病毒中的反应性硫化合物
Antioxidants (Basel). 2022 May 26;11(6):1053. doi: 10.3390/antiox11061053.
10
Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.治疗靶点：SARS-CoV-2 感染诱导的细胞死亡。
Front Immunol. 2022 May 17;13:870216. doi: 10.3389/fimmu.2022.870216. eCollection 2022.
本文引用的文献
1
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy.COVID-19 对肝功能的影响：来自意大利北部某内科病房的结果。
Intern Emerg Med. 2020 Nov;15(8):1399-1407. doi: 10.1007/s11739-020-02425-w. Epub 2020 Jul 10.
2
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
3
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).2019新型冠状病毒（2019-nCoV）的治疗选择。
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
4
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes.二硫化硒可通过不同模式抑制 MERS 和 SARS 冠状病毒木瓜蛋白酶样蛋白酶。
Antiviral Res. 2018 Feb;150:155-163. doi: 10.1016/j.antiviral.2017.12.015. Epub 2017 Dec 28.
Zotero 插件